Document is current
Any future updates will be listed below
-
Authors
Many, Gina M. https://orcid.org/0000-0003-4779-1690
Sanford, James A. https://orcid.org/0000-0001-7901-5579
Sagendorf, Tyler J. https://orcid.org/0000-0003-1552-4870
Hou, Zhenxin https://orcid.org/0000-0002-1301-0799
Nigro, Pasquale https://orcid.org/0000-0002-2918-8356
Whytock, Katie L. https://orcid.org/0000-0003-3486-9452
Amar, David https://orcid.org/0000-0002-9719-0837
Caputo, Tiziana https://orcid.org/0000-0002-3854-5677
Gay, Nicole R. https://orcid.org/0000-0001-9138-9354
Gaul, David A. https://orcid.org/0000-0002-9308-1895
Hirshman, Michael F. https://orcid.org/0000-0001-8728-6379
Jimenez-Morales, David https://orcid.org/0000-0003-4356-6461
Lindholm, Malene E. https://orcid.org/0000-0002-5763-7833
Muehlbauer, Michael J.
Vamvini, Maria https://orcid.org/0000-0002-1532-1689
Bergman, Bryan C. https://orcid.org/0000-0002-9561-1052
Fernández, Facundo M. https://orcid.org/0000-0002-0302-2534
Goodyear, Laurie J. https://orcid.org/0000-0002-6299-2928
Hevener, Andrea L. https://orcid.org/0000-0003-1508-4377
Ortlund, Eric A. https://orcid.org/0000-0001-8855-3029
Sparks, Lauren M. https://orcid.org/0000-0002-8724-6016
Xia, Ashley
Adkins, Joshua N. https://orcid.org/0000-0003-0399-0700
Bodine, Sue C. https://orcid.org/0000-0002-5742-9145
Newgard, Christopher B. https://orcid.org/0000-0002-1293-691X
Schenk, Simon https://orcid.org/0000-0002-8224-3203
,
Armenteros, Jose Juan Almagro
Amper, Mary Anne S.
Ashley, Euan
Asokan, Aneesh Kumar
Avila-Pacheco, Julian
Bae, Dam
Bamman, Marcas M.
Bararpour, Nasim
Barnes, Jerry
Buford, Thomas W.
Burant, Charles F.
Carbone, Nicholas P.
Carr, Steven A.
Chambers, Toby L.
Chavez, Clarisa
Chiu, Roxanne
Clish, Clary B.
Cutter, Gary R.
Dasari, Surendra
Dennis, Courtney
Evans, Charles R.
Fernandez, Facundo M.
Gagne, Nicole
Ge, Yongchao
Goodpaster, Bret H.
Gritsenko, Marina A.
Hansen, Joshua R.
Hennig, Krista M.
Huffman, Kim M.
Hung, Chia-Jui
Hutchinson-Bunch, Chelsea
Ilkayeva, Olga
Ivanova, Anna A.
Beltran, Pierre M. Jean
Jin, Christopher A.
Kachman, Maureen T.
Keshishian, Hasmik
Kraus, William E.
Lanza, Ian
Lester, Bridget
Li, Jun Z.
Lira, Ana K.
Liu, Xueyun
Maner-Smith, Kristal M.
May, Sandy
Monroe, Matthew R.
Montgomery, Stephen
Moore, Ronald J.
Moore, Samuel G.
Nachun, Daniel
Nair, K. Sreekumaran
Nair, Venugopalan
Raja, Archana Natarajan
Nestor, Michael D.
Nudelman, German
Petyuk, Vladislav A.
Piehowski, Paul D.
Pincas, Hanna
Qian, Wei-Jun
Raskind, Alexander
Rasmussen, Blake B.
Rooney, Jessica L.
Rushing, Scott
Samdarshi, Mihir
Sealfon, Stuart C.
Smith, Kevin S.
Smith, Gregory R.
Snyder, Michael
Stowe, Cynthia L.
Talton, Jennifer W.
Teng, Christopher
Thalacker-Mercer, Anna
Tracy, Russell
Trappe, Todd A.
Vasoya, Mital
Vetr, Nikolai G.
Volpi, Elena
Walkup, Michael P.
Walsh, Martin J.
Wheeler, Matthew T.
Wu, Si
Zaslavsky, Elena
Zebarjadi, Navid
Zhang, Tiantian
Zhao, Bingqing
Zhen, Jimmy
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (U24DK112349, U24DK112341, U24DK112340, U24DK112341)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (U01AG055135, U01AG055133)
- License Information
-
More Information
Article History
Received: 2 February 2023
Accepted: 1 December 2023
First Online: 1 May 2024
Competing interests
: S.C.B. has equity in Emmyon. G.R.C. sits on data and safety monitoring boards for AI Therapeutics, AMO Pharma, AstraZeneca, Avexis Pharmaceuticals, BioLineRx, Brainstorm Cell Therapeutics, Bristol Myers Squibb/Celgene, CSL Behring, Galmed Pharmaceuticals, Green Valley Pharma, Horizon Pharmaceuticals, Immunic, Mapi Pharmaceuticals, Merck, Mitsubishi Tanabe Pharma Holdings, Opko Biologics, Prothena Biosciences, Novartis, Regeneron, Sanofi-Aventis, Reata Pharmaceuticals, NHLBI (Protocol Review Committee), University of Texas Southwestern, University of Pennsylvania, Visioneering Technologies, serves on Consulting or Advisory Boards for Alexion, Antisense Therapeutics, Biogen, Clinical Trial Solutions, Genzyme, Genentech, GW Pharmaceuticals, Immunic, Klein-Buendel Incorporated, Merck/Serono, Novartis, Osmotica Pharmaceuticals, Perception Neurosciences, Protalix Biotherapeutics, Recursion/CereXis Pharmaceuticals, Regeneron, Roche, SAB Biotherapeutics and is the President of Pythagoras, a private consulting company located in Birmingham. S.A.C. is a member of the scientific advisory boards of Kymera, PrognomiQ, PTM BioLabs and Seer. M.P.S. is a cofounder and scientific advisor of Personalis, Qbio, January AI, Filtricine, SensOmics, Protos, Fodsel, Rthm, Marble and is a scientific advisor for Genapsys, Swaz and Jupiter. S.B.M. is a consultant for BioMarin, MyOme and Tenaya Therapeutics. S.S. is a consultant for Terns Pharmaceuticals. All other authors declare no competing interests.
